Management of Antiplatelet Therapy in Patients with Coronary Stents Undergoing Noncardiac Surgery

Am J Med. 2022 Sep;135(9):e305-e307. doi: 10.1016/j.amjmed.2022.05.014. Epub 2022 May 28.

Authors

Nidhi Rohatgi¹, James L Zehnder², Nathaniel R Smilowitz³

Affiliations

¹ Division of Hospital Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, Calif. Electronic address: nrohatgi@stanford.edu.
² Division of Hematology, Department of Medicine and Clinical Pathology, Stanford University School of Medicine, Stanford, Calif.
³ Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, NY.

PMID: 35636479
DOI: 10.1016/j.amjmed.2022.05.014

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural

MeSH terms

Humans
Perioperative Care
Platelet Aggregation Inhibitors* / therapeutic use
Risk Factors
Stents
Surgical Procedures, Operative*

Substances

Platelet Aggregation Inhibitors

Grants and funding

K23 HL150315/HL/NHLBI NIH HHS/United States